Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Non Operating Interest Expenses (2010 - 2026)

Updated

Skinvisible's Non Operating Interest Expenses was $142,716 in Q2 2026, unchanged from $142,720 a year earlier and up 1.0% from the prior quarter.

Analysis

Skinvisible (SKVI) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Skinvisible's Non Operating Interest Expenses was $572,338 through Jun 30, 2026, down 7.7% year-over-year; for FY2025, it was $572,249, down 14.5% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of -13.7% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $669,438 in FY2024 (-64.5%), $1.89 million in FY2023 (+62.3%), $1.16 million in FY2022 (-4.1%) and $1.21 million in FY2021 (+1.6%).
  • Quarterly Non Operating Interest Expenses has moved between $141,153 (Q1 2025) and $1.38 million (Q1 2023) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in two of the last eight quarters, with an average decline of 7.2%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q1 2023 (growth of 378.0%); the worst was Q1 2024 (a decline of 88.0%).
  • Per Business Quant data, SKVI's Non Operating Interest Expenses in the three quarters before Q2 2026 was $141,246 (Q1 2026), $144,188 (Q4 2025) and $144,188 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Skinvisible 1.08 Mn 1.07 Mn 5,000.00 142,716.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142,716.00
Mar 31, 2026 141,246.00
Dec 31, 2025 144,188.00
Sep 30, 2025 144,188.00
Jun 30, 2025 142,720.00
Mar 31, 2025 141,153.00
Dec 31, 2024 168,663.00
Sep 30, 2024 167,757.00
Jun 30, 2024 166,610.00
Mar 31, 2024 166,408.00
Dec 31, 2023 167,757.00
Sep 30, 2023 167,757.00
Jun 30, 2023 167,522.00
Mar 31, 2023 1.38 Mn
Dec 31, 2022 291,177.00
Sep 30, 2022 291,178.00
Jun 30, 2022 290,945.00
Mar 31, 2022 289,569.00
Dec 31, 2021 326,836.00
Sep 30, 2021 294,216.00
API Access

Skinvisible Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SKVI&period=max&api_key=YOUR_API_KEY